Skip to Content

771 (Lansoprazole Delayed-Release (Orally Disintegrating) 15 mg)

Pill with imprint 771 is White, Round and has been identified as Lansoprazole Delayed-Release (Orally Disintegrating) 15 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Lansoprazole is used in the treatment of barrett's esophagus; duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 771

Lansoprazole Delayed-Release (Orally Disintegrating)

Imprint
771
Strength
15 mg
Color
White
Shape
Round
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
70771-1132

Get help with Imprint Code FAQs.

Related Images for "771"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.